Genentech

Founded in 1976, Genentech, Inc. is a pioneering biotechnology company headquartered in South San Francisco, California. As an independent subsidiary of Roche since 2009, Genentech focuses on advancing science to solve complex biomedical challenges. The company offers a range of groundbreaking products, including Avastin, Herceptin, Rituxan, and Tecentriq, targeting various medical conditions such as cancer and autoimmune diseases. Genentech's mission is to push the boundaries of science to improve human health and transform lives.

Notable figures associated with Genentech include Severin Schwan, Chairman of the Board and CEO of Roche Group, and Aviv Regev, a prominent scientist. The company has achieved significant milestones, including the development of life-saving therapies and maintaining a strong pipeline of innovative drugs. Genentech's impact on the biotechnology industry is profound, as it continues to lead in research and development, contributing to advancements in personalized medicine and improving patient outcomes globally.